|
|
![]() |
|
|
![]() |
||||||||||||||||||||||||||||||||||||||
About MPS I MPS I is a progressive, debilitating and often life-threatening disease. It is an inherited disorder caused by a deficiency of an enzyme called alpha-L-iduronidase (pronounced al-fa el eye-dur-on-I-dase). This enzyme is required for the breakdown of certain substances in the body commonly referred to as GAG (glycosaminoglycans). As more and more GAG builds up in a person's body, almost all organs can be irreversibly damaged. Therefore, early diagnosis and treatment of MPS I is important. MPS I has also been called Hurler, Hurler-Scheie, and Scheie Syndromes. The incidence of MPS I is estimated to be between one in 144,000 births for Hurler Syndrome, and one in 1.3 million for Scheie Syndrome. Even though many people with MPS I have the same enzyme deficiency, they may experience a wide range of symptoms and many people have different degrees of disease severity. People with the most severe form of MPS I typically suffer from a number of symptoms that worsen over time, including mental retardation. Their lifespan is approximately eight to ten years. Individuals at the opposite end of the spectrum may have symptoms that can be as severe, but they generally have regular mental power and physical build. They may also have a normal life span. For more information about MPS1 contact your doctor or other healthcare professional or the following patient associations: MPS I Disease MPS I Registry Mucopolysaccharide and Related Diseases Society Aust. Ltd This site is intended for use by Australian and New Zealand residents only. |
|
||||||||||||||||||||||||||||||||||||||
|
Terms and Conditions of Use | Privacy Policy | © 2003-2009 Genzyme Corporation. All rights reserved. |